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Abstract: With a relatively large surface area (2 m2) and 15% of total body mass, the skin forms
the largest organ of the human body. The main functions of the skin include regulation of body
temperature by insulation or sweating, regulation of the nervous system, regulation of water content,
and protection against external injury. To perform these critical functions, the skin encodes genes for
transporters responsible for the cellular trafficking of essential nutrients and metabolites to maintain
cellular hemostasis. However, the knowledge on the expression, regulation, and function of these
transporters is very limited and needs more work to elucidate how these transporters play a role both
in disease progression and in healing. Furthermore, SLC and ABC transporters are understudied,
and even less studied in skin. There are sparse reports on relation between transporters in skin and
sweat metabolites. This mini review focuses on the current state of SLC and ABC transporters in the
skin and their relation to sweat metabolites and skin diseases.
Keywords: sweat metabolites; ABC transporters; SLC transporters; skin diseases; skin trans-
porters; KNIME
1. Introduction
Skin is the largest organ of the body. It is usually soft, flexible and contains multiple
layers, i.e., the stratum corneum, epidermis, dermis, and subcutaneous tissue and a myriad
of cells with different functions (Figure 1). The skin comprises of two barriers that protect
the body from environmental factors: One physical (stratum corneum) and one biochem-
ical (epidermis and dermis). Nerves, glands, hair follicles, ducts, and blood vessels are
embedded beneath the surface of the skin.
The skin has a well-established role in regulating body temperature by preventing
excessive water loss through the stratum corneum [1] and by excreting water in the form
of sweat. Sweat is produced by sweat glands in the dermis and reaches the epithelial
surface of the skin through tiny ducts. Sweat glands are involved in perspiration and
act as an excretory organ not only to efflux water and dilute electrolyte solution but also
drugs and their metabolites [2]. There are three different types of sweat glands: Eccrine,
apocrine, and apoeccrine. Eccrine sweat glands are extensively distributed across most
of the body’s surface area and mainly secrete water and electrolytes. They directly open
onto the skin surface by a duct and are responsible for large amounts of sweat production.
Apocrine glands usually develop in association with hair follicles and open into them
and secrete oily substances containing lipids, proteins, sugars, and ammonia through hair
canals and are found only in skin containing hair such as the axilla, face, mammary, and
genital areas [3,4]. Rather than responding to temperature, apocrine glands often respond
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to emotional stimulus, including anxiety, pain, and fear, and under these circumstances,
sweating is often observed in the armpits, palms, and soles of the feet [3,4]. Apocrine
glands are distributed in the same areas as apocrine glands but secrete watery fluids similar
to eccrine glands [2]. Apoeccrine sweat glands are not widely reported. Like apocrine
glands, they are limited to a specific area of the skin, i.e., only in the axillary area. Like
eccrine glands, they secrete water and electrolytes directly onto the skin [5,6]. These glands
may be useful in determining the secondary functions of sweat as evaporation is ineffective
in the axillary region [6,7].
Figure 1. Schematic representation of skin. Created in biorender.com (accessed on 29 March 2021).
Sweat is normally a transparent body fluid with low tonicity and a slightly acidic
nature with mean pH 6.3 [8]. Additionally, sweat metabolites are used as biomarkers
for a variety of diseases [9]. Water is the main component of sweat ∼99% [8]. Moreover,
sweat comprises a mixture of many chemicals in varying concentrations, including metal
and nonmetal ions (e.g., Na+, K+, Ca2+, Mg2+, Fe2+, Zn2+, Cl−, and vitamins) as well
as metabolites such as glucose, pyruvate, lactate, ammonia, urea, bicarbonate, amino
acids, ethanol, cytokines, xenobiotics, betaine, and cortisol. The amount of Na+ and
Cl− is the highest, ranging approximately from 10 mmol/L up to 90 mmol/L. Other
compounds are present at a lower millimolar concentration (lactate, ethanol, urea, ammonia,
bicarbonate, and K+), micromolar concentrations (Ca2+, Mg2+, Fe2+, Zn2+, Cu2+, ascorbic
acid, glucose, and individual amino acids) or even smaller scale, nanomolar and picomolar
concentrations (thiamine, cortisol, and cytokines) [7]. The efflux of electrolytes, such as
Na+, K.+, Cl−, occurs through Na+–K+-ATPase, K+ and Cl- channels on the basolateral
and apical membrane [10]. There is evidence that some membrane transport proteins are
also responsible for both uptake and secretion of sweat metabolites, especially when it
comes to metal ions [11].
Membrane transport proteins play an important role in the translocation of different
endogenous and exogenous components (compounds, nutrients, metals, etc.) across
plasma membranes [11]. Membrane transporters are widely distributed throughout the
body, particularly in the epithelia of major organs, such as the liver, intestine, kidney, and
other organs with barrier functions, such as the brain, skin, testes, and placenta [11–16].
Membrane transport proteins in humans are largely composed of two families: ATP-
binding cassette (ABC) and solute carrier (SLC) transporters. ABC transporters are active
transporters and utilize the energy of ATP binding (Figure 2) and hydrolysis to facilitate
in- or efflux of their substrates across membranes [17–19] while on the other hand, SLC
transporters (Figure 3) utilize ion electrochemical gradients, such as sodium or proton
gradients for the uphill transport of the substrates [20].
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Figure 2. Schematic representation of the secondary structure of ABC transporters. N terminus in
orange, C terminus in blue, NBD stands for nucleotide-binding domain. Created with biorender.com
(accessed on 29 March 2021).
Figure 3. Schematic representation of the secondary structure of SLC transporters. N terminus in
orange, C terminus in blue. Created with biorender.com (accessed on 29 March 2021).
As of now, 49 ABC transporters subtypes have been identified in humans, which are
divided into 7 subfamilies ABCA, ABCB, ABCC, ABCD, ABCE, ABCF, and ABCG [19,21].
These transport a broad spectrum of endogenous substrates, including lipids (ABCA1 and
ABCG family) [21–24], cholesterol (ABCG1) [25], iron (ABCB6–10) [26], organic anions
(ABCC2), peptides (ABCB2 and 3), and bile salts (ABCB11) [27], as well as exogenous
compounds, such as drugs across intra- and extracellular membranes [28]. In contrast,
there are approximately 400 SLC transmembrane transporters that are divided into six
groups. 66 distinct subfamilies (SLC1 to SLC66) have been identified [20,29].
Like ABC family members, they transport various compounds ranging from the
cellular uptake of nutrients to the absorption of xenobiotics [30]. Their function in the
translocation of substrates can be described using four models: Cotransporter or symporter
(SLC1 and SLC5), antiporters (SLC4 and SLC26), facilitated (SLC2) (Figure 4), and a few
of them are ‘orphan transporter’ for which substrates and functions need to be identi-
fied [31]. In humans, ABC transporters mostly perform efflux functions by eliminating
xenobiotics out of the body [32], while the SLC transport systems can be influxers, effluxers,
or antiporters. A few SLC transporters have the ability for bidirectional transport [33]
as well.
The present review will focus on the role of ABC and SLC transport proteins present
in the skin and their correlation to sweat metabolites. A list of sweat metabolites was
obtained from the human metabolome database (https://hmdb.ca/downloads accessed
on 15 March 2021) [34]. Interestingly, very little evidence is available on the expression of
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different ABC and SLC transporters in the skin [35–38], and a thorough investigation is
urgently needed to gain deeper insights into the role of SLC and ABC transporters in the
skin and their relation to metabolites in sweat.
Figure 4. Schematic representation of the three types of SLC transporters. Created with biorender.com
(accessed on 29 March 2021).
2. The Role of Proteomics in the Identification of Skin SLC and ABC Transporters
To investigate the role of transporters and other components of human skin, scientists
have, for many years, used gene expression analysis. With the development of mass
spectrometry (MS) analysis, we can now use MS-based proteomics approaches as a tool
for quantification and identification of proteins in humans [39,40]. The advances in this
technology have also allowed higher sensitivity when characterizing and analyzing large
proteomes [41,42]. Knowledge about skin composition, especially the role of many trans-
porters found in the skin, is limited. Recent studies have used proteomic investigation
to try to capture the complexity of the skin [41]. The layered composition comprising
of the inner and outer epidermis has been studied using in-depth MS-based proteomics
utilizing both data-dependent acquisition and data-independent acquisition approaches.
Using proteomics to investigate skin cell type diversity, including keratinocytes, fibroblasts,
melanocytes, endothelial, and immune cells, revealed quantification of a total of 10,701 pro-
teins and these findings have provided essential information for the unique systems and
functions of each cell type within the skin complex [41].
Mass spectrometry-based proteomics uses label-free and label-based approaches.
Label-free methods allow the identification of the abundance of many proteins, such as
enzymes found in the human skin, and this knowledge is pivotal in our understanding of
skin physiology and function. Most recently, for the first time, a label-free quantification of
enzymes in human skin has been reported [43]. The study used this approach to compare
proteins found in human skin and those in 3D models mimicking human skin. Here,
ABC transporters ABCA8 and ABCB11 and eight SLC transporters (SLC12A2, SLC25A3,
SLC25A5, SLC25A6, SLC29A1, SLC44A1, SLC44A2, SLC4A1) have been quantified in
human skin along with xenobiotic-metabolizing enzymes (XME). ABC and other skin
transporters regulate local drug concentrations in different tissues. Therefore, detection
and quantification of their expression levels are important. Proteomics sample preparation
can be challenging and especially when working with skin since this tissue contains a high
lipid content and proteins with a high degree of crosslinking. It is even more challenging
to quantify ABC transporters because they are large and low in abundance, which is
close to the detection limit of liquid-chromatography tandem mass spectrometry (LC-
MS/MS). ABC transporters found in the skin also share high homology (e.g., ABCB1,
ABCB4, ABCB11, ABCA1, and ABCA2), and therefore, when analyzing these proteins,
adjustments in the data analysis are necessary. For example, when publishing data sets, it
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is relevant to report the total intensities of unique peptides across all samples [38] along
with the intensities of the shared peptides assigned according to the general ratio of the
uniquely observed peptide intensities. Such analysis has been recently reported in a study
where 32 ABC transporters across five tissues have been quantified [38].
Some of the sample preparation techniques include incubation in lysis buffer, homoge-
nization, filtration, digestion, and sometimes enrichment [38,43]. Sample preparation plays
an important role in the detection of these membrane proteins. Conventional methods
such as 2D-gel electrophoresis did not result in significant protein yield [44]. Recently, dif-
ferent strategies have evolved, such as powdering the frozen tissues (from liquid nitrogen),
and subsequent protein extraction has led to 10-fold increase in the number of identified
proteins. Another strategy was an improvement to the existing tape stripping strategy in
tandem with the state-of-the-art SP3 (single-pot solid phase enhanced sample preparation)
approach [45,46]. This has led to an increase in the number of identified peptides. Different
labs have different procedures, and the current state is that several methods should be used
in tandem for lysing cells, extraction of proteins (more thorough screening of detergents is
needed to extract and enrich membrane proteins), and purification of the tryptic digest.
3. Correlation between Sweat Metabolome and Skin SLC and ABC Transporters
We made a list of transport proteins characterized in the skin and tried to identify
their substrates present in the sweat metabolites. Several ABC transporters are expressed
in the skin [36], although none of them has been implicated with the transport of sweat
metabolites in human skin, to the best of our knowledge. To confirm the same, we have
utilized an advanced data mining tool KNIME. KNIME stands for Konstanz information
MinEr, which is freely downloadable via www.knime.org, with compatibility over different
operating systems, including Linux, MacOS, and Windows. KNIME operates in the form
of workflows consisting of different nodes. Nodes are a part of workflow that, when
bolted together, can allow computational operations ranging from something as simple as
transposing a table, to performing advanced machine learning algorithms at the click of a
button. To create workflows, nodes can simply be dragged and dropped into the workflow
environment. More than 10,000 nodes are available in the node repository. With little
knowledge of programming, one can create custom nodes in standard scripting languages
such as MATLAB, R, Python, PERL, and JAVA [47,48].
To understand if sweat metabolites are in any way related to skin SLC and ABC trans-
porters, we have utilized a premade workflow “Term co-occurrence heatmap” (https://www.
knime.com/term-coocurrence-heatmap-example accessed on 15 March 2021, Figure 5),
modified using KNIME version 4.3.1.
The workflow uses the protein names of the compiled SLC and ABC genes listed in
Table 1 as search terms on PubMed, and up to 100 abstracts of resulting articles are down-
loaded and saved in a temporary directory. The metabolites are then used as dictionary
terms, to discover if the metabolites are mentioned in the abstracts. If metabolites and
proteins are related, then those documents are tagged, and untagged documents are fil-
tered. The tagged documents are traced back to the transporters used as a search term, and
the co-occurrences can thus be determined. Finally, heatmaps illustrating co-occurrences
between transporters and metabolites were prepared using R. To remove false positives,
we have added a filter where we filtered the entries with less than five co-occurrences. The
remaining entries were scaled between 0 (white; metabolite cooccurred with the transporter
less than five times) and 1 (black; metabolite that cooccurred with a transporter most). All
the gray scales were the fractions between 0–1.
This workflow gave output in the form of heatmaps (Figure 6 ABC transporter) and
(Figure 7 SLC transporter).
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Figure 5. KNIME workflow used to map the co-occurrences of sweat metabolites vs. skin SLC and ABC transporters.
Customized from original. https://www.knime.com/term-coocurrence-heatmap-example (accessed on 15 March 2021).
Skin encodes for many ABC transporters, but very little evidence of co-relation be-
tween sweat metabolites and ABC transporters was observed. MDR1, also known as
P-gp (ABCB1), MRP’s, SUR2 (ABCC9) [36,49–51], are expressed in the skin and are known
to efflux a wide variety of drugs [32], but not much information on their real substrates
is available.
For SLC transporters, we observed a stronger correlation with sweat metabolites.
For example, SLC 36 transports glycine [52]. SLC7A1 and 2 are cationic amino acid
transporters [53] and correlates well with arginine and ornithine. Similarly, SLC4 and 5
are glucose and bicarbonate transporters. They are multi-functional, allowing the passage
for water channels and urea [54–56]. Glucose comprises one of the most well-known
constituents of sweat. Glucose is the primary carbon source for the proliferative cells, four
different SLC families have been detected to transport glucose, GLUT’s (SLC2A1–14), SGLT
(SLC5), SWEET’s (SLC50), and SLC 60(A1–A2) of which GLUT’s have been observed to
be expressed in the skin [57,58]. Lactate and pyruvates are also observed in sweat and
these are generally transported by SLC16 family of transporters (MCT1–14) and several of
them were observed to be expressed in skin [59]. Several amino acids were also observed
in ‘faux sweat’ and skin encodes for many amino acid transporters such as SLC7 and
SLC36 [60–62]. Urea transporters (efflux transporter) have been detected in sweat glands of
skin [63], and its presence as a sweat metabolite possibly indicates the role of sweat glands
in urea excretion. A detailed list of transporters is listed in Table 1.
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Figure 6. Co-occurrences of sweat metabolites with ABC transporter proteins.
Figure 7. Co-occurrences of sweat metabolites with SLC transporter proteins.
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Table 1. List of transporters present in skin, including whether they were identified by mRNA-based methods or MS-based
proteomics (marked with *).















3 ABCC1(DOMINANT) * [49]
ABCG2,ABCB1,ABCC2 (relatively less) * [49]
4 ABCC3 (most abundant) * [35]
ABCB1,ABCA7,ABCG2 (less abundant) * [35]
ABCA2,ABCC1 (moderately abundant) * [35]
SLC22A3(most abundant) * [35]
SLCO3A1,SLC16A7,SLCO2B1(moderately abundant) * [35]





6 SLC14 (1 and 2) * [63]
7 SLC47A1 and SLC47A2 * [64]
4. The Implication of SLC and ABC Transporters in the Skin and Related Diseases
SLC and ABC transporters in the skin are understudied and relatively few reports
are available on their relation to skin diseases. SLC36A1/PAT1 is responsible for the
champagne dilution phenotype in horses characterized by dilution of hair color intensity
in both red and black pigments. The color of the horse changes from chestnut to gold
champagne, bay to amber champagne, and black to classic champagne [65]. Lactate is
a metabolite found in sweat, which is a breakdown product of glucose. The transport
of lactate is mediated by SLC16 (monocarboxylate transporters, MCT) expressed in the
skin [66]. When studied with chicken choroid explants for wound healing, MCT3 has
been reported to be lost, while increased expression of MCT4 was observed following
a scratch [67]. Furthermore, a minor deposition of lactate in the cells and tissue under
oxygenated condition is itself sufficient for wound healing with the full sequence of vascu-
logenesis and collagen deposition phase. Lactate enhances the set of activities for wound
healing as endothelial cell mobility, increased collagen synthesis and its post-transitional
modification and deposition and cell proliferation [68]. Furthermore, GLUT1 has been
shown to be a promising drug target to treat psoriasis. Deletion of GLUT1 decreased
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hyperplasia in mice and topical application of GLUT1 inhibitor reduced inflammation
in psoriatic organoids models. GLUT1 was reported to be required by keratinocytes for
injury/inflammation associated proliferation [69]. Identification of urea transporters in the
skin opens many possibilities to treat uremic patients by creating a “sweating kidney” as
they have increased expression levels of SLC14A1–2 transporters in sweat glands. Contrary
to these findings, urea transporters are involved in the uremic frost as well. Therefore, there
is an increasing need to study these specific transporters in detail using suitable ex-vivo,
in-vivo, and in-vitro models [70].
Similarly, ABCC6 is implicated with a rare genetic recessive disorder pseudoxan-
thoma elasticum resulting in mineralization of elastic tissues, including skin [71]. The real
substrate for ABCC6 is still unknown and although localized in mitochondria-associated
membrane [51,72]. Wounds are again another area related to the skin where minimal
information is available in connection to skin SLC and ABC transporters. Post-injury,
the 4-stage healing process (hemostasis, inflammation, proliferation, and remodeling) be-
gins naturally and many biochemicals, such as growth factors, chemokines, cytokines,
extracellular matrix and regulatory molecules, participate in the process [73,74]. Arginine
plays an important role in wound healing, being a precursor to proline and ornithine,
which are responsible for the synthesis of nitric oxide and collagen. Nitric oxide under
oxygenated conditions creates the reactive oxygen species required for gene expression and
cellular differentiation. Inhibition of nitric oxide resulted in decreased collagen synthesis
and impaired wound healing [75]. ABCG2 expression is required for proper expansion
and differentiation of epidermal stem cells (reside in a bulge of a hair follicle). ABCG’s
knockouts resulted in elevated levels of reactive oxygen species and damage DNA leading
to proliferation arrest [76].
5. Conclusions
The area of transporters and solute carriers, in general, is under-investigated as com-
pared to other classes of membrane proteins and even less studied in the skin. Currently,
the approaches utilized are either based on mRNA measurements (>80% of times) and
direct proteins measurements (<20%) using mass spectrometry. There is an utmost need to
utilize both methods together and correlate them to total skin and sweat metabolites to
gain a better understanding of physiological processes occurring in the skin. This will not
only enable the scientists to understand the pathophysiology of skin diseases better but
also aid in developing suitable formulations for topical delivery of pharmaceuticals.
Author Contributions: Conceptualization, B.K.P., B.M. and H.J.; methodology, E.A., B.K.P., H.J. and
B.M.; software, M.M.K.H., B.K.P. and E.A.; validation, B.K.P., H.J., B.M., M.M.K.H. and E.S.; formal
analysis, E.S.; investigation, E.S.; resources, E.S., M.M.K.H., E.A. and B.K.P.; data curation, M.M.K.H.,
E.A. and E.S.; writing—B.K.P., E.S., E.A., M.M.K.H., B.M and H.J.; writing—review and editing,
B.M., H.J. and B.K.P.; visualization, E.S., E.A. and M.M.K.H.; supervision, B.K.P. and H.J.; project
administration, B.K.P., B.M. and H.J.; funding acquisition, B.K.P. and H.J. All authors have read and
agreed to the published version of the manuscript.
Funding: The research received no external funding.
Data Availability Statement: The KNIME workflow is available from the corresponding author
upon request.
Conflicts of Interest: There are no potential conflict of interest.
References
1. Tsuruta, D.; Green, K.J.; Getsios, S.; Jones, J.C.R. The barrier function of skin: How to keep a tight lid on water loss. Trends Cell Biol.
2002, 12, 355–357. [CrossRef]
2. Wilke, K.; Martin, A.; Terstegen, L.; Biel, S.S. A short history of sweat gland biology. Int. J. Cosmet. Sci. 2007, 29, 169–179.
[CrossRef]
3. Groscurth, P. Anatomy of sweat glands. Curr. Probl. Dermatol. 2002, 30, 1–9. [CrossRef] [PubMed]
4. Hodge, B.D.; Sanvictores, T.; Brodell, R.T. Anatomy, Skin Sweat Glands; StatPearls: Treasure Island, FL, USA, 2021.
Proteomes 2021, 9, 23 10 of 12
5. Sato, K.; Leidal, R.; Sato, F. Morphology and development of an apoeccrine sweat gland in human axillae. Am. J. Physiol. 1987,
252, 166–180. [CrossRef] [PubMed]
6. Sato, K.; Sato, F. Sweat secretion by human axillary apoeccrine sweat gland in vitro. Am. J. Physiol. 1987, 252, 181–187. [CrossRef]
7. Baker, L.B. Physiology of sweat gland function: The roles of sweating and sweat composition in human health. Temperature 2019,
6, 211–259. [CrossRef]
8. Sato, K.; Kang, W.H.; Saga, K.; Sato, K.T. Biology of sweat glands and their disorders. I. Normal sweat gland function. J. Am.
Acad. Dermatol. 1989, 20, 537–563. [CrossRef]
9. Jadoon, S.; Karim, S.; Akram, M.R.; Kalsoom Khan, A.; Zia, M.A.; Siddiqi, A.R.; Murtaza, G. Recent developments in sweat
analysis and its applications. Int. J. Anal. Chem. 2015, 2015. [CrossRef]
10. Saint-Criq, V.; Gray, M.A. Role of CFTR in epithelial physiology. Cell. Mol. Life Sci. 2017, 74, 93–115. [CrossRef]
11. Kell, D.B. What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?
Trends Pharm. Sci. 2015, 36, 15–21. [CrossRef]
12. Kell, D.B. The transporter-mediated cellular uptake of pharmaceutical drugs is based on their metabolite-likeness and not on
their bulk biophysical properties: Towards a systems pharmacology. Perspect. Sci. 2015, 6, 66–83. [CrossRef]
13. Kell, D.B. Transport—Linked Phosphorylation: Problems and Prospects. Curr. Top. Cell. Regul. 1992, 289, 1–12. [CrossRef]
14. Kell, D.B.; Dobson, P.D.; Bilsland, E.; Oliver, S.G. The promiscuous binding of pharmaceutical drugs and their transporter-
mediated uptake into cells: What we (need to) know and how we can do so. Drug Discov. Today 2013, 18, 218–239. [CrossRef]
15. Kell, D.B.; Dobson, P.D.; Oliver, S.G. Pharmaceutical drug transport: The issues and the implications that it is essentially
carrier-mediated only. Drug Discov. Today 2011, 16, 704–714. [CrossRef] [PubMed]
16. Kell, D.B.; Oliver, S.G. How drugs get into cells: Tested and testable predictions to help discriminate between transporter-mediated
uptake and lipoidal bilayer diffusion. Front. Pharm. 2014, 5, 1–32. [CrossRef]
17. Alexander, S.P.H.; Kelly, E.; Mathie, A.; Peters, J.A.; Veale, E.L.; Armstrong, J.F.; Faccenda, E.; Harding, S.D.; Pawson, A.J.;
Sharman, J.L.; et al. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters. Br. J. Pharm. 2019, 176, S397–S493.
[CrossRef]
18. Babcock, J.J.; Li, M. Deorphanizing the human transmembrane genome: A landscape of uncharacterized membrane proteins.
Acta Pharm. Sin. 2014, 35, 11–23. [CrossRef]
19. Dean, M.; Hamon, Y.; Chimini, G. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001, 42,
1007–1017. [CrossRef]
20. Hediger, M.A.; Romero, M.F.; Peng, J.-B.; Rolfs, A.; Takanaga, H.; Bruford, E.A. The ABCs of solute carriers: Physiological,
pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch. 2004, 447, 465–468.
[CrossRef] [PubMed]
21. Borst, P.; Zelcer, N.; Van Helvoort, A. ABC transporters in lipid transport. Biochim. Biophys Acta. 2000, 1486, 128–144. [CrossRef]
22. Ruetz, S.; Gros, P. Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell 1994, 77, 1071–1081. [CrossRef]
23. Schmitz, G.; Kaminski, W.E.; Orsó, E. ABC transporters in cellular lipid trafficking. Curr. Opin. Lipidol. 2000, 11, 493–501.
[CrossRef]
24. Schmitz, G.; Langmann, T.; Heimerl, S. Role of ABCG1 and other ABCG family members in lipid metabolism. J. Lipid. Res. 2001,
42, 1513–1520. [CrossRef]
25. Lu, K.; Lee, M.H.; Patel, S.B. Dietary cholesterol absorption; more than just bile. Trends Endocrinol. Metab. 2001, 12, 314–320.
[CrossRef]
26. Seguin, A.; Ward, D.M. Mitochondrial ABC Transporters and Iron Metabolism. Int. J. Clin. Exp. Pathol. 2018, 08, 1–5. [CrossRef]
27. Vasiliou, V.; Vasiliou, K.; Nebert, D.W. Human ATP-binding cassette (ABC) transporter family. Hum. Genom. 2009, 3, 281.
[CrossRef]
28. Glavinas, H.; Krajcsi, P.; Cserepes, J.; Sarkadi, B. The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity.
Curr. Drug Deliv. 2005, 1, 27–42. [CrossRef]
29. Perland, E.; Fredriksson, R. Classification Systems of Secondary Active Transporters. Trends Pharm. Sci. 2017, 38, 305–315.
[CrossRef] [PubMed]
30. Lin, L.; Yee, S.W.; Kim, R.B.; Giacomini, K.M. SLC transporters as therapeutic targets: Emerging opportunities. Nat. Rev.
Drug Discov. 2015, 14, 543–560. [CrossRef]
31. Zhang, Y.; Zhang, Y.; Sun, K.; Meng, Z.; Chen, L. The SLC transporter in nutrient and metabolic sensing, regulation, and drug
development. J. Mol. Cell Biol. 2018, 11, 1–13. [CrossRef]
32. El-Awady, R.; Saleh, E.; Hashim, A.; Soliman, N.; Dallah, A.; Elrasheed, A.; Elakraa, G. The Role of Eukaryotic and Prokaryotic
ABC Transporter Family in Failure of Chemotherapy. Front. Pharm. 2017, 7. [CrossRef] [PubMed]
33. Kottra, G.; Daniel, H. Bidirectional electrogenic transport of peptides by the proton-coupled carrier PEPT1 in Xenopus laevis
oocytes: Its asymmetry and symmetry. J. Physiol. 2001, 536, 495–503. [CrossRef] [PubMed]
34. Wishart, D.S.; Feunang, Y.D.; Marcu, A.; Guo, A.C.; Liang, K.; Vazquez-Fresno, R.; Sajed, T.; Johnson, D.; Li, C.; Karu, N.; et al.
HMDB 4.0: The human metabolome database for 2018. Nucleic Acids Res. 2018, 46, 608–617. [CrossRef]
35. Takechi, T.; Hirota, T.; Sakai, T.; Maeda, N.; Kobayashi, D.; Ieiri, I. Interindividual differences in the expression of atp-binding
cassette and solute carrier family transporters in human skin: Dna methylation regulates transcriptional activity of the human
abcc3 gene. Drug Metab. Dispos. 2018, 46, 628–635. [CrossRef] [PubMed]
Proteomes 2021, 9, 23 11 of 12
36. Takenaka, S.; Itoh, T.; Fujiwara, R. Expression pattern of human ATP-binding cassette transporters in skin. Pharm. Res. Perspect.
2013, 1, e00005. [CrossRef] [PubMed]
37. Fujiwara, R.; Takenaka, S.; Hashimoto, M.; Narawa, T.; Itoh, T. Expression of human solute carrier family transporters in skin:
Possible contributor to drug-induced skin disorders. Sci. Rep. 2014, 4, 5251. [CrossRef] [PubMed]
38. Al-Majdoub, Z.M.; Achour, B.; Couto, N.; Howard, M.; Elmorsi, Y.; Scotcher, D.; Alrubia, S.; El-Khateeb, E.; Vasilogianni, A.-M.;
Alohali, N.; et al. Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin.
FEBS Lett. 2020, 594, 4134–4150. [CrossRef]
39. Aebersold, R.; Mann, M. Mass-spectrometric exploration of proteome structure and function. Nature 2016, 537, 347–355. [CrossRef]
[PubMed]
40. Larance, M.; Lamond, A.I. Multidimensional proteomics for cell biology. Nat. Rev. Mol. Cell Biol. 2015, 16, 269–280. [CrossRef]
[PubMed]
41. Dyring-Andersen, B.; Løvendorf, M.B.; Coscia, F.; Santos, A.; Møller, L.B.P.; Colaço, A.R.; Niu, L.; Bzorek, M.; Doll, S.;
Andersen, J.L.; et al. Spatially and cell-type resolved quantitative proteomic atlas of healthy human skin. Nat. Commun.
2020, 11, 5587. [CrossRef]
42. Wang, D.; Eraslan, B.; Wieland, T.; Hallström, B.; Hopf, T.; Zolg, D.P.; Zecha, J.; Asplund, A.; Li, L.-h.; Meng, C.; et al. A deep
proteome and transcriptome abundance atlas of 29 healthy human tissues. Mol. Syst. Biol. 2019, 15, e8503. [CrossRef] [PubMed]
43. Couto, N.; Newton, J.R.A.; Russo, C.; Karunakaran, E.; Achour, B.; Al-Majdoub, Z.M.; Sidaway, J.; Rostami-Hodjegan, A.; Clench,
M.R.; Barber, J. Label-free Quantitative Proteomics and Substrate Based Mass Spectrometry Imaging of Xenobiotic Metabolizing
Enzymes in ex Vivo Human Skin and a Human Living Skin Equivalent Model. Drug Metab. Dispos. 2020, 49, 39–52. [CrossRef]
[PubMed]
44. Bliss, E.; Heywood, W.E.; Benatti, M.; Sebire, N.J.; Mills, K. An optimised method for the proteomic profiling of full thickness
human skin. Biol. Proced. Online 2016, 18, 15. [CrossRef] [PubMed]
45. Hughes, C.S.; Foehr, S.; Garfield, D.A.; Furlong, E.E.; Steinmetz, L.M.; Krijgsveld, J. Ultrasensitive proteome analysis using
paramagnetic bead technology. Mol. Syst. Biol. 2014, 10, 757. [CrossRef]
46. Kaleja, P.; Emmert, H.; Gerstel, U.; Weidinger, S.; Tholey, A. Evaluation and improvement of protein extraction methods for
analysis of skin proteome by noninvasive tape stripping. J. Proteom. 2020, 217, 103678. [CrossRef]
47. O’Hagan, S.; Kell, D.B. Software review: The KNIME workflow environment and its applications in genetic programming and
machine learning. Genet. Program. Evolvable. Mach. 2015, 16, 387–391. [CrossRef]
48. Fillbrunn, A.; Dietz, C.; Pfeuffer, J.; Rahn, R.; Landrum, G.A.; Berthold, M.R. KNIME for reproducible cross-domain analysis of
life science data. J. Biotechnol. 2017, 261, 149–156. [CrossRef]
49. Osman-Ponchet, H.; Boulai, A.; Kouidhi, M.; Sevin, K.; Alriquet, M.; Gaborit, A.; Bertino, B.; Comby, P.; Ruty, B. Characterization
of ABC transporters in human skin. Drug Metabol. Drug Interact. 2014, 29, 91–100. [CrossRef]
50. Okamura, N.; Sakaeda, T.; Okumura, K. Pharmacogenomics of MDR and MRP subfamilies. Pers. Med. 2004, 1, 85–104. [CrossRef]
51. Hendig, D.; Langmann, T.; Fau-Kocken, S.; Kocken, S.; Fau-Zarbock, R.; Zarbock, R.; Fau-Szliska, C.; Szliska, C.; Fau-Schmitz, G.;
Schmitz, G.; et al. Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients
identifies new candidates involved in PXE pathogenesis. Lab. Investig. 2008, 88, 1303–1315. [CrossRef]
52. Boll, M.; Daniel, H.; Gasnier, B. The SLC36 family: Proton-coupled transporters for the absorption of selected amino acids from
extracellular and intracellular proteolysis. Pflug. Arch. 2004, 447, 776–779. [CrossRef]
53. Shen, L.; Qian, C.; Cao, H.; Wang, Z.; Luo, T.; Liang, C. Upregulation of the solute carrier family 7 genes is indicative of poor
prognosis in papillary thyroid carcinoma. World J. Surg. Oncol. 2018, 16, 235. [CrossRef] [PubMed]
54. Wright, E.M. Glucose transport families SLC5 and SLC50. Mol. Asp. Med. 2013, 34, 183–196. [CrossRef] [PubMed]
55. Wright, E.M.; Turk, E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004. [CrossRef]
56. Romero, M.F.; Fulton, C.M.; Boron, W.F. The SLC4 family of HCO3- transporters. Mol. Asp. Med. 2004, 447, 495–509. [CrossRef]
57. Oh, C.S.; Hong, J.H.; Jin, S.N.; Lee, W.J.; Lee, Y.S.; Lee, E. Expression of glucose transporters in the developing rat skin.
Anat. Cell Biol. 2017, 50, 214–218. [CrossRef] [PubMed]
58. Gherzi, R.; Melioli, G.; de Luca, M.; D’Agostino, A.; Distefano, G.; Guastella, M.; D’Anna, F.; Franzi, A.T.; Cancedda, R.
“HepG2/erythroid/brain” type glucose transporter (GLUT1) is highly expressed in human epidermis: Keratinocyte differentiation
affects glut1 levels in reconstituted epidermis. J. Cell. Physiol. 1992, 150, 463–474. [CrossRef]
59. Bonen, A.; Heynen, M.; Hatta, H. Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal
muscle. Appl. Physiol. Nutr. Metab. 2006, 31, 31–39. [CrossRef]
60. Cibrian, D.; Castillo-González, R.; Fernández-Gallego, N.; de la Fuente, H.; Jorge, I.; Saiz, M.L.; Punzón, C.; Ramírez-Huesca, M.;
Vicente-Manzanares, M.; Fresno, M.; et al. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently
controls skin inflammation. J. Allergy Clin. Immunol. 2020, 145, 199–214. [CrossRef] [PubMed]
61. Schnorr, O.; Suschek, C.V.; Kolb-Bachofen, V. The importance of cationic amino acid transporter expression in human skin.
J. Investig. Derm. 2003, 120, 1016–1022. [CrossRef]
62. Jensen, A.; Figueiredo-Larsen, M.; Holm, R.; Broberg, M.L.; Brodin, B.; Nielsen, C.U. PAT1 (SLC36A1) shows nuclear localization
and affects growth of smooth muscle cells from rats. Am. J. Physiol. Endocrinol. Metab. 2014, 306, E65–E74. [CrossRef]
63. Xie, L.; Jin, L.; Feng, J.; Lv, J. The expression of AQP5 and UTs in the sweat glands of uremic patients. BioMed Res. Int. 2017, 2017,
8629783. [CrossRef] [PubMed]
Proteomes 2021, 9, 23 12 of 12
64. Alriquet, M.; Sevin, K.; Gaborit, A.; Comby, P.; Ruty, B.; Osman-Ponchet, H. Characterization of SLC transporters in human skin.
Admet Dmpk 2015, 3, 34–44. [CrossRef]
65. Cook, D.; Brooks S Fau-Bellone, R.; Bellone R Fau-Bailey, E.; Bailey, E. Missense mutation in exon 2 of SLC36A1 responsible for
champagne dilution in horses. PLoS Genet. 2008, 4, e1000195. [CrossRef] [PubMed]
66. Gallagher, S.M.; Castorino, J.J.; Philp, N.J. Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell
migration. Am. J. Physiol. Cell Physiol. 2009, 296, C414–C421. [CrossRef]
67. Gallagher-Colombo, S.; Maminishkis, A.; Fau-Tate, S.; Tate, S.; Fau-Grunwald, G.B.; Grunwald, G.B.; Fau-Philp, N.J.; Philp, N.J.
Modulation of MCT3 expression during wound healing of the retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 2010, 51,
5343–5350. [CrossRef]
68. Porporato, P.E.; Payen, V.L.; De Saedeleer, C.J.; Préat, V.; Thissen, J.-P.; Feron, O.; Sonveaux, P. Lactate stimulates angiogenesis and
accelerates the healing of superficial and ischemic wounds in mice. Angiogenesis 2012, 15, 581–592. [CrossRef]
69. Zhang, Z.; Zi, Z.; Lee, E.E.; Zhao, J.; Contreras, D.C.; South, A.P.; Abel, E.D.; Chong, B.F.; Vandergriff, T.; Hosler, G.A.; et al.
Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis article. Nat. Med. 2018,
24, 617–627. [CrossRef] [PubMed]
70. Klein, J.D.; Sands, J.M. Urea transport and clinical potential of urearetics. Curr. Opin. Nephrol. Hypertens 2016, 25, 444–451.
[CrossRef]
71. Váradi, A.; Szabó, Z.; Pomozi, V.; de Boussac, H.; Fülöp, K.; Arányi, T. ABCC6 as a target in pseudoxanthoma elasticum.
Curr. Drug Targets 2011, 12, 671–682. [CrossRef]
72. Martin, L.J.; Lau, E.; Singh, H.; Vergnes, L.; Tarling, E.J.; Mehrabian, M.; Mungrue, I.; Xiao, S.; Shih, D.; Castellani, L.; et al. ABCC6
localizes to the mitochondria-associated membrane. Circ. Res. 2012, 111, 516–520. [CrossRef] [PubMed]
73. Cañedo-Dorantes, L.; Cañedo-Ayala, M. Skin Acute Wound Healing: A Comprehensive Review. Int. J. Inflam. 2019, 2019, 3706315.
[CrossRef] [PubMed]
74. Gomes, A.; Teixeira, C.; Ferraz, R.; Prudêncio, C.; Gomes, P. Wound-Healing Peptides for Treatment of Chronic Diabetic Foot
Ulcers and Other Infected Skin Injuries. Molecules 2017, 22, 1743. [CrossRef] [PubMed]
75. Witte, M.B.; Barbul, A. Arginine physiology and its implication for wound healing. Wound Repair Regen. 2003, 11, 419–423.
[CrossRef] [PubMed]
76. Chang, H.-M.; Huang, W.-Y.; Lin, S.-J.; Huang, W.-C.; Shen, C.-R.; Mao, W.-Y.; Shen, C.-N. ABCG2 deficiency in skin impairs
re-epithelialization in cutaneous wound healing. Exp. Derm. 2016, 25, 355–361. [CrossRef] [PubMed]
